Publications by authors named "Luc Sauriol"

Claim this Profile
T
The Use of Computer Simulation Modeling to Estimate Complications in Patients with Type 2 Diabetes Mellitus: Comparative Validation of the Cornerstone Diabetes Simulation Model.
Zhuo T Su, Jose Bartelt-Hofer, Stephen Brown, Elisheva Lew, Luc Sauriol

Pharmacoecon Open· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study.
Alexander Abitbol, Ruth E Brown, Dishay Jiandani, Luc Sauriol, Ronnie Aronson

Can J Diabetes· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic analysis of insulin initiation by pharmacists in a Canadian setting: The RxING study.
Stephen Brown, Yazid N Al Hamarneh, Ross T Tsuyuki, Kimberley Nehme, Luc Sauriol

Can Pharm J (Ott)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study.
Yazid N Al Hamarneh, Luc Sauriol, Ross T Tsuyuki

BMJ Open· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of insulin glargine versus sitagliptin in insulin-naïve patients with type 2 diabetes mellitus.
Stephen T Brown, Daniel Grima Grima, Luc Sauriol

Clin Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of dronedarone in patients with atrial fibrillation in the ATHENA trial.
Jenny Berg, Luc Sauriol, Stuart Connolly, Peter Lindgren

Can J Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of atrial fibrillation on the hospital sector in Canada.
Daria J O'Reilly, Robert B Hopkins, Jeff S Healey, Paul Dorian, Luc Sauriol

Can J Cardiol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic Characteristics and Patterns of Medication in Atrial Fibrillation Patients in South West Ontario: Insights from a Large Primary Care Database.
Robert J Petrella, Luc Sauriol

J Atr Fibrillation· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial fibrillation: a real-life observational study in the Québec population.
Jason R Guertin, Marc Dorais, Paul Khairy, Luc Sauriol, Alexis Matteau

Can J Cardiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada.
Sandra L Tunis, Luc Sauriol, Michael E Minshall

Appl Health Econ Health Policy· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial.
Rober C Welsh, Luc Sauriol, Zugui Zhang, Paul Kolm, Willian S Weintraub

Can J Cardiol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study.
Robyn Houlden, Stuart Ross, Stewart Harris, Jean-Francois Yale, Luc Sauriol

Diabetes Res Clin Pract· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada.
Daniel T Grima, Melissa F Thompson, Luc Sauriol

Pharmacoeconomics· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risking health to avoid injections: preferences of Canadians with type 2 diabetes.
A Brett Hauber, F Reed Johnson, Luc Sauriol, Benedicte Lescrauwaet

Diabetes Care· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis and economic evaluation of LH-RH agonists' depot formulations in advanced prostatic carcinoma.
Karine Alloul, Luc Sauriol, Louise Lafortune

Can J Urol· August 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis